| 時間枠 | 予想価格 | 過去 | 歴史的 | 洞察力 |
|---|---|---|---|---|
| 明日 | $1.55 ▲ +1.68% | 昨日 | $1.51 ▼ -0.71% | Tomorrow's Actinium Pharmaceuticals Inc. (Delaware) Common Stock (ATNM) setup is anchored to $1.52 and targets $1.55 (+1.68%). The near-term read is upside; watch $1.57 / $1.47 because daily realized volatility is about 8.00%. |
Tomorrow's Actinium Pharmaceuticals Inc. (Delaware) Common Stock (ATNM) setup is anchored to $1.52 and targets $1.55 (+1.68%). The near-term read is upside; watch $1.57 / $1.47 because daily realized volatility is about 8.00%. | ||||
| 週 | $1.60 ▲ +5.23% | 先週 | $1.49 ▼ -2.19% | The 7-day Actinium Pharmaceuticals Inc. (Delaware) Common Stock model moves from $1.49 to $1.60 (+5.23%). It gives upside momentum context for this stock, so breaks around $1.57 / $1.47 matter more than a single tick. |
The 7-day Actinium Pharmaceuticals Inc. (Delaware) Common Stock model moves from $1.49 to $1.60 (+5.23%). It gives upside momentum context for this stock, so breaks around $1.57 / $1.47 matter more than a single tick. | ||||
| 月 | $1.69 ▲ +11.13% | 先月 | $1.45 ▼ -4.67% | The 1-month Actinium Pharmaceuticals Inc. (Delaware) Common Stock target is $1.69 (+11.13%), compared with the live reference near $1.52. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk. |
The 1-month Actinium Pharmaceuticals Inc. (Delaware) Common Stock target is $1.69 (+11.13%), compared with the live reference near $1.52. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk. | ||||
| 年 | $1.82 ▲ +19.98% | 去年 | $1.39 ▼ -8.39% | The 1-year Actinium Pharmaceuticals Inc. (Delaware) Common Stock scenario points to $1.82 (+19.98%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates. |
The 1-year Actinium Pharmaceuticals Inc. (Delaware) Common Stock scenario points to $1.82 (+19.98%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates. | ||||
| 5年 | $2.14 ▲ +40.71% | 5年前 | $1.26 ▼ -17.10% | The 5-year Actinium Pharmaceuticals Inc. (Delaware) Common Stock view is $2.14 (+40.71%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path. |
The 5-year Actinium Pharmaceuticals Inc. (Delaware) Common Stock view is $2.14 (+40.71%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path. | ||||
| インジケータ | 価値 | 信号 |
|---|---|---|
| Price | $1.52 | Mid |
| Daily Change | +5.56% | Above |
| Volatility Cap | 20.0% | Mid |
| Confidence | 69% | Above |
| Data Source | nasdaq-screener | Mid |
| Current | $1.52 | Daily Change | +5.56% |
| Market Cap | $47.69M | Source | nasdaq-screener |
Related ideas for internal navigation, grouped by stronger upside and weaker downside setups in the same market.